Thomas C. Reynolds - Jul 15, 2025 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role: Director
Signature: /s/ Thomas C. Reynolds
Stock symbol: MEIP
Transactions as of: Jul 15, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/17/2025, 09:39 PM
Previous filing: Oct 12, 2023
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Reynolds Thomas C	Director	C/O MEI PHARMA, INC., 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO	/s/ Thomas C. Reynolds	2025-07-17	0001393945

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MEIP	Common Stock						500	Jul 15, 2025	Direct

Showing 1 to 1 of 1 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MEIP	Stock Option (Right to Buy)	Award	$0	+20K		$0.00	20K	Jul 15, 2025	Common Stock	20K	$3.07	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.